European Medicines Agency: Alofisel Withdrawn From the EU Market
December 14, 2024
December 14, 2024
LONDON, England, Dec. 14 (TNSres) -- The European Medicines Agency issued the following news:
* * *
Benefit of medicine used in Crohn's disease no longer demonstrated
* * *
Data from a recent study have shown that Alofisel, a medicine used to treat complex anal fistulas (abnormal passages between the lower parts of the gut and the skin near the anus) in adults with Crohn's disease, does not work well enough. The available data indicate that the . . .
* * *
Benefit of medicine used in Crohn's disease no longer demonstrated
* * *
Data from a recent study have shown that Alofisel, a medicine used to treat complex anal fistulas (abnormal passages between the lower parts of the gut and the skin near the anus) in adults with Crohn's disease, does not work well enough. The available data indicate that the . . .